FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2238130276> ?p ?o ?g. }

• W2238130276 endingPage "7298" @default.
• W2238130276 startingPage "7290" @default.
• W2238130276 abstract "Extensive preclinical evaluation of griffithsin (GRFT) has identified this lectin to be a promising broad-spectrum microbicide. We set out to explore the antiviral properties of a GRFT and carrageenan (CG) combination product against herpes simplex virus 2 (HSV-2) and human papillomavirus (HPV) as well as determine the mechanism of action (MOA) of GRFT against both viruses. We performed the experiments in different cell lines, using time-of-addition and temperature dependence experiments to differentiate inhibition of viral attachment from entry and viral receptor internalization. Surface plasmon resonance (SPR) was used to assess GRFT binding to viral glycoproteins, and immunoprecipitation and immunohistochemistry were used to identify the specific glycoprotein involved. We determined the antiviral activity of GRFT against HSV-2 to be a 50% effective concentration (EC50) of 230 nM and provide the first evidence that GRFT has moderate anti-HPV activity (EC50 = 0.429 to 1.39 μM). GRFT blocks the entry of HSV-2 and HPV into target cells but not the adsorption of HSV-2 and HPV onto target cells. The results of the SPR, immunoprecipitation, and immunohistochemistry analyses of HSV-2 combined suggest that GRFT may block viral entry by binding to HSV-2 glycoprotein D. Cell-based assays suggest anti-HPV activity through α6 integrin internalization. The GRFT-CG combination product but not GRFT or CG alone reduced HSV-2 vaginal infection in mice when given an hour before challenge (P = 0.0352). While GRFT significantly protected mice against vaginal HPV infection when dosed during and after HPV16 pseudovirus challenge (P < 0.026), greater CG-mediated protection was afforded by the GRFT-CG combination for up to 8 h (P < 0.0022). These findings support the development of the GRFT-CG combination as a broad-spectrum microbicide." @default.
• W2238130276 created "2016-06-24" @default.
• W2238130276 creator A5014635371 @default.
• W2238130276 creator A5017827760 @default.
• W2238130276 creator A5021230194 @default.
• W2238130276 creator A5026538989 @default.
• W2238130276 creator A5037452645 @default.
• W2238130276 creator A5044975908 @default.
• W2238130276 creator A5046784911 @default.
• W2238130276 creator A5049998171 @default.
• W2238130276 creator A5053915358 @default.
• W2238130276 creator A5067064525 @default.
• W2238130276 creator A5076096752 @default.
• W2238130276 creator A5089579849 @default.
• W2238130276 date "2015-12-01" @default.
• W2238130276 modified "2023-10-12" @default.
• W2238130276 title "Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus" @default.
• W2238130276 cites W1495765538 @default.
• W2238130276 cites W1527415307 @default.
• W2238130276 cites W1529453182 @default.
• W2238130276 cites W1542886234 @default.
• W2238130276 cites W1695142101 @default.
• W2238130276 cites W1715558547 @default.
• W2238130276 cites W1762854803 @default.
• W2238130276 cites W1828182586 @default.
• W2238130276 cites W1964533994 @default.
• W2238130276 cites W1965514049 @default.
• W2238130276 cites W1977610810 @default.
• W2238130276 cites W1981594691 @default.
• W2238130276 cites W1991135717 @default.
• W2238130276 cites W2006057279 @default.
• W2238130276 cites W2015067929 @default.
• W2238130276 cites W2024800512 @default.
• W2238130276 cites W2025400889 @default.
• W2238130276 cites W2027373982 @default.
• W2238130276 cites W2069266754 @default.
• W2238130276 cites W2071644212 @default.
• W2238130276 cites W2076189032 @default.
• W2238130276 cites W2076224189 @default.
• W2238130276 cites W2079028174 @default.
• W2238130276 cites W2089043305 @default.
• W2238130276 cites W2095038585 @default.
• W2238130276 cites W2096039378 @default.
• W2238130276 cites W2098337603 @default.
• W2238130276 cites W2102255881 @default.
• W2238130276 cites W2105035717 @default.
• W2238130276 cites W2120919816 @default.
• W2238130276 cites W2121085803 @default.
• W2238130276 cites W2121528674 @default.
• W2238130276 cites W2123565921 @default.
• W2238130276 cites W2125372939 @default.
• W2238130276 cites W2125678197 @default.
• W2238130276 cites W2131243228 @default.
• W2238130276 cites W2144198686 @default.
• W2238130276 cites W2147201324 @default.
• W2238130276 cites W2150417136 @default.
• W2238130276 cites W2150924565 @default.
• W2238130276 cites W2154097024 @default.
• W2238130276 cites W2169183716 @default.
• W2238130276 cites W2412635390 @default.
• W2238130276 cites W2432158033 @default.
• W2238130276 doi "https://doi.org/10.1128/aac.01816-15" @default.
• W2238130276 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4649164" @default.
• W2238130276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26369967" @default.
• W2238130276 hasPublicationYear "2015" @default.
• W2238130276 type Work @default.
• W2238130276 sameAs 2238130276 @default.
• W2238130276 citedByCount "74" @default.
• W2238130276 countsByYear W22381302762016 @default.
• W2238130276 countsByYear W22381302762017 @default.
• W2238130276 countsByYear W22381302762018 @default.
• W2238130276 countsByYear W22381302762019 @default.
• W2238130276 countsByYear W22381302762020 @default.
• W2238130276 countsByYear W22381302762021 @default.
• W2238130276 countsByYear W22381302762022 @default.
• W2238130276 countsByYear W22381302762023 @default.
• W2238130276 crossrefType "journal-article" @default.
• W2238130276 hasAuthorship W2238130276A5014635371 @default.
• W2238130276 hasAuthorship W2238130276A5017827760 @default.
• W2238130276 hasAuthorship W2238130276A5021230194 @default.
• W2238130276 hasAuthorship W2238130276A5026538989 @default.
• W2238130276 hasAuthorship W2238130276A5037452645 @default.
• W2238130276 hasAuthorship W2238130276A5044975908 @default.
• W2238130276 hasAuthorship W2238130276A5046784911 @default.
• W2238130276 hasAuthorship W2238130276A5049998171 @default.
• W2238130276 hasAuthorship W2238130276A5053915358 @default.
• W2238130276 hasAuthorship W2238130276A5067064525 @default.
• W2238130276 hasAuthorship W2238130276A5076096752 @default.
• W2238130276 hasAuthorship W2238130276A5089579849 @default.
• W2238130276 hasBestOaLocation W22381302761 @default.
• W2238130276 hasConcept C140704245 @default.
• W2238130276 hasConcept C159047783 @default.
• W2238130276 hasConcept C2522874641 @default.
• W2238130276 hasConcept C2776997796 @default.
• W2238130276 hasConcept C2781196997 @default.
• W2238130276 hasConcept C58475186 @default.
• W2238130276 hasConcept C86803240 @default.
• W2238130276 hasConceptScore W2238130276C140704245 @default.

• next